Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
Sebastian Klapa, Specialist in Internal Medicine and Rheumatology at University of Lübeck, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press
ANCA-associated vasculitis (AAV) and the risk of mortality and cardiovascular morbidity.
In our recent paper, which has been accepted by Frontiers-Immunology, we focused on real-world data for mortality and a wide range of cardiovascular diseases in an enlarged cohort of over 20,000 AAV patients over a period of up to 20 years.
For the first time, we were able to compare over 5,000 MPA patients with GPA patients.
Key findings:
- Increased risk of death in AAV patients
- Elevated risk of all screened cardiovascular comorbidities, especially major adverse cardiac events (MACE)
- MPA patients presented an increased risk of MACE and peripheral arterial disease
Be aware of your AAV patients, even those in stable remission.
In addition to symptom-related diagnostics, we may need to regularly screen for cardiovascular diseases.
Many thanks to all the co-authors for their great contributions!”
Title: ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study
Authors: Sebastian Klapa, Katja Bieber, Artem Vorobyev, Marlene Ludwig, Gordon Vollert, Sabrina Arnold, Henning Olbrich, Henry Nording, Antje Müller, Khalaf Kridin, Jan Henrik Schirmer, Katja von Allwörden, Anja Staehle, Ralf Ludwig, Peter Lamprecht

Stay updated on all scientific advances with Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF